Jasper Therapeutics, Inc. (JSPR) announced it received a notice from The Nasdaq Stock Market on August 21, 2026, indicating the company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. The notice has no immediate effect on the trading of the company's common stock.
Key Details
- Compliance Issue: The company's stockholders' equity fell below the required minimum of $2,500,000, as reported in its Quarterly Report for the period ended June 30, 2026.
- Timeline to Comply: Jasper has until October 5, 2026 (45 calendar days) to submit a plan to Nasdaq to regain compliance.
- Proposed Action: The company plans to regain compliance by seeking stockholder approval for the conversion of its outstanding Non-Voting Convertible Preferred Stock. If its compliance plan is accepted, Nasdaq may grant an extension of up to 180 days to meet the requirement.